These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15270300

  • 1. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy].
    Mikhaĭlova SV, Zakharova EIu, Bukina AM, Il'ina ES, Pokrovskaia AIa, Fedoniuk ID, Bembeeva RTs, Petrukhin AS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300
    [No Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB, Geiss-Holtorff R, Rolland MO, Pryds O, Müller-Forell W, Christensen E, Lehnert W, Lou HC, Ott D, Hennig J.
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [Abstract] [Full Text] [Related]

  • 3. Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
    Leone P, Janson CG, McPhee SJ, During MJ.
    Curr Opin Mol Ther; 1999 Aug; 1(4):487-92. PubMed ID: 11713764
    [Abstract] [Full Text] [Related]

  • 4. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
    Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A, Wang DJ, Shera D, Hurh P, Rupin J, Saslow E, Goldfarb O, Goldberg M, Larijani G, Sharrar W, Liouterman L, Camp A, Kolodny E, Samulski J, Leone P.
    Hum Gene Ther; 2002 Jul 20; 13(11):1391-412. PubMed ID: 12162821
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of Canavan disease.
    Matalon R, Michals-Matalon K.
    Eur J Paediatr Neurol; 1998 Jul 20; 2(2):69-76. PubMed ID: 10724099
    [No Abstract] [Full Text] [Related]

  • 6. Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease.
    Drenckhahn A, Schuelke M, Knierim E.
    J Inherit Metab Dis; 2015 Sep 20; 38(5):983-4. PubMed ID: 25647544
    [Abstract] [Full Text] [Related]

  • 7. Atypical MRI findings in Canavan disease: a patient with a mild course.
    Yalcinkaya C, Benbir G, Salomons GS, Karaarslan E, Rolland MO, Jakobs C, van der Knaap MS.
    Neuropediatrics; 2005 Oct 20; 36(5):336-9. PubMed ID: 16217711
    [Abstract] [Full Text] [Related]

  • 8. Recent advances in Canavan disease.
    Matalon R, Michals-Matalon K.
    Adv Pediatr; 1999 Oct 20; 46():493-506. PubMed ID: 10645473
    [Abstract] [Full Text] [Related]

  • 9. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
    Velinov M, Zellers N, Styles J, Wisniewski K.
    Clin Genet; 2008 Mar 20; 73(3):288-9. PubMed ID: 18070137
    [No Abstract] [Full Text] [Related]

  • 10. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G, Spencer ZHT, Rowlands BD, Klugmann CB, Bongers A, Harasta AE, Parley KE, Cederholm J, Teahan O, Pickford R, Delerue F, Ittner LM, Fröhlich D, McLean CA, Don AS, Schneider M, Housley GD, Rae CD, Klugmann M.
    Acta Neuropathol; 2018 Jan 20; 135(1):95-113. PubMed ID: 29116375
    [Abstract] [Full Text] [Related]

  • 11. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ.
    Mol Ther; 2005 May 20; 11(5):745-53. PubMed ID: 15851013
    [Abstract] [Full Text] [Related]

  • 12. Biochemistry and molecular biology of Canavan disease.
    Matalon R, Michals-Matalon K.
    Neurochem Res; 1999 Apr 20; 24(4):507-13. PubMed ID: 10227683
    [Abstract] [Full Text] [Related]

  • 13. Relationship between enzyme properties and disease progression in Canavan disease.
    Zano S, Wijayasinghe YS, Malik R, Smith J, Viola RE.
    J Inherit Metab Dis; 2013 Jan 20; 36(1):1-6. PubMed ID: 22850825
    [Abstract] [Full Text] [Related]

  • 14. Restricted diffusion in Canavan disease.
    Srikanth SG, Chandrashekar HS, Nagarajan K, Jayakumar PN.
    Childs Nerv Syst; 2007 Apr 20; 23(4):465-8. PubMed ID: 17219235
    [Abstract] [Full Text] [Related]

  • 15. A case of Canavan disease: the first biochemically proven case in a Japanese girl.
    Hamaguchi H, Nihei K, Nakamoto N, Ezoe T, Naito H, Hara M, Yokota K, Inoue Y, Matsumoto I.
    Brain Dev; 1993 Apr 20; 15(5):367-71. PubMed ID: 8279652
    [Abstract] [Full Text] [Related]

  • 16. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K, Lin A, Bhattacharya P, Tran T, Wong W, Ross B.
    Adv Exp Med Biol; 2006 Apr 20; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract] [Full Text] [Related]

  • 17. Atypical clinical and radiological course of a patient with Canavan disease.
    Sarret C, Boespflug-Tanguy O, Rodriguez D.
    Metab Brain Dis; 2016 Apr 20; 31(2):475-9. PubMed ID: 26586007
    [Abstract] [Full Text] [Related]

  • 18. Dietary treatment proposed for Canavan's disease.
    Chen V.
    Lancet Neurol; 2005 May 20; 4(5):273. PubMed ID: 15861552
    [No Abstract] [Full Text] [Related]

  • 19. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L, Chaabane F, Tilouche S, Chabchoub I, Kabachi N, Tlili K, Yacoub M, Essoussi AS.
    Arch Pediatr; 2007 Feb 20; 14(2):173-6. PubMed ID: 17196380
    [Abstract] [Full Text] [Related]

  • 20. Juvenile Canavan Disease: A Leukodystrophy without White Matter Changes.
    Jauhari P, Saini L, Chakrabarty B, Kumar A, Gulati S.
    Neuropediatrics; 2018 Dec 20; 49(6):420-421. PubMed ID: 30304741
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.